{'fraction_non_alphanumeric': 0.029605263157894735, 'fraction_numerical': 0.008771929824561403, 'mean_word_length': 5.615942028985507, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 1, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Evaluation of a new homogeneous enzyme inhibitor immunoassay of serum thyroxine with use of a bichromatic analyzer.

We evaluated a new homogeneous enzyme immunoassay of thyroxine with use of a discrete analyzer (the ABA-100 Bichromatic Analyzer), modified with an auxiliary dispenser assembly. The assay is based on inhibition of hydrolysis of the substrate, acetyl-beta-(methylthio)choline iodide, by acetylcholinesterase (acetylcholine hydrolase; EC 3.1.1.7). Thyroxine covalently linked to a cholinesterase inhibitor irreversibly inhibits acetylcholinesterase, but if this thyroxine conjugate is bound to antibody it is not inhibitory. Seventy-five patients' samples may be analyzed in 1 h of instrument time. Precision and accuracy are excellent, results correlate well with those by radioimmunoassay, and there were no instances of confused clinical interpretation resulting from use of the proposed assay.